An infusion drug that treats a uncommon illness has caught the attention of attorneys, who’ve filed over a dozen circumstances with extra anticipated within the months forward.
The drug, Tepezza, which the U.S. Meals and Drug Administration accepted in 2020, treats thyroid eye illness by way of intravenous infusions.
Youth-led climate change lawsuits gain momentum with backing of liberal, dark money group Fox Information Source link
Embattled social media platform TikTok stated Friday that Common Counsel Erich Andersen has stepped all the way down to deal...
Geo Group Announces Settlement in Shareholder Litigation - TipRanks.com TipRanks Source link
How I Made Legislation Agency Management: 'Each Lawyer's Foreign money Is Their Personal Apply,' Says Jason Novak of Norton Rose...
